Three Symposia, Three Years of Fellows, One Mission: Medscape Oncology at ASCO 2026
May 14, 2026 | #ASCO26 #medscapeoncology, MedEd
Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) with another ambitious oncology program.
Three Symposia at the Hilton Chicago
- The Reality of Care for HER2-Mutated Advanced NSCLC: Closing Community Gaps — Saturday, May 30, 6:15–7:45 PM CT, International Ballroom South. Supported by Bayer.
- Redefining the Patient Journey: The Promise and Practice in NTRK Fusion-Positive Cancers — Sunday, May 31, 6:30–8:00 PM CT, International Ballroom South. Supported by Bayer.
- A Case-Based Guide for CD38-Targeted Monoclonal Antibody Therapy in the Treatment of Multiple Myeloma — Sunday, May 31, 6:30–7:30 PM CT, International Ballroom North. Supported by Sanofi, in partnership with the International Myeloma Foundation.
Online Poster
Medscape Oncology will also be presenting outcomes research as an e-poster: The Impact of Online CME on Addressing Clinical Decision-Making for Immunotherapy in Advanced Squamous NSCLC. Authors: Michelle A. Worst, PharmD, BCOP, MBA, CHCP; Andrew Small; Amy Furedy, RN, OCN; Charu Aggarwal, MD, MPH; Sandip Patel, MD
ASCO Fellows, Year Three
For the third consecutive year, Medscape Oncology is supporting a cohort of Fellows to attend ASCO. Fellows will spend time on the booth in focus groups, go hands-on with Medscape AI and the new medical simulation solution, Clinical Readiness Studio as well as engaging with faculty across the program.
“There is no better time to understand what oncology clinicians actually need than at the start of their specialist careers. Our Fellows tell us where the evidence gaps are, where the tools fall short, and what the next generation expects from medical education. That insight is irreplaceable, and it directly shapes what we build and what we publish. Alongside the symposia and Medscape AI, the Fellows program is central to why we show up at ASCO the way we do,” said Chris Hoffman, Chief Strategy Officer, Medscape Education.
Medscape AI on the Booth
Medscape AI represents a new generation of clinical intelligence and research tools, drawing exclusively on a clinically validated knowledge base of expert-authored content, peer-reviewed journals, and rigorously vetted medical sources, with every response traceable to verifiable citations. Oncology is the most-queried specialty on Medscape AI, with breast cancer and lymphoma topping the list. A recent analysis of platform queries also found that diagnosis support and treatment decisions account for half of all physician queries across specialties.
An Indispensable Resource for Oncologists
Medscape has been delivering oncology education, medical information, and clinical tools for over 30 years. In a recent survey of hem/onc members, 79% recognised it as an indispensable resource, 78% would recommend it to colleagues, and 75% call it their preferred CME website. The trust is there. ASCO 2026 is where we put it to work.
Find the team at Booth #10099 or reach out to Jelena Spyropoulos at jspyropoulos@medscape.net.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Using AI Responsibly in CME Outcomes Reporting
ICYMI at #AIS2026: using AI in outcomes reporting is a lot like onboarding a research assistant. There’s real efficiency in having the help, and a significant amount of background teaching,…
The Pulse of AI Innovation: From More Data to Better Care
At the European Society of Cardiology (ESC) Congress, two of cardiology’s most influential voices sat down to talk about artificial intelligence at Medscape’s ‘The Pulse of AI Innovation’ event: Professor…
Next-Level Clinical Practice, Real-World Impact: Evolving Patient Simulation with the Clinical Readiness Studio
Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical mastery requires active experience, the confidence to make decisions when real patient outcomes…
Medscape Sponsors The John Ritter Foundation’s “Evening From the Heart”
When independent, evidence-based education directly connects with clinicians at the point of care, clinical practice changes. Driven by this vital mission, Medscape Education was proud to sponsor The John Ritter…
From Booth to Bavaria: A Recap of Impact at ESC 2026
We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have already shown: when independent, evidence-based…
Why Modern Dermatology Demands Curiosity Over Precision
In the high-stakes world of healthcare research and product development, success has long been measured by rigid definitions of precision and predictable trajectories. However, as Dr. Hawa Dumbuya, Director of…
The Heart of the Matter: Medscape Education’s Cardiology Footprint at ESC 2026
For more than 30 years, Medscape Education has built independent, accredited cardiovascular education designed around one goal: improved patient outcomes. This year at the European Society of Cardiology Congress (ESC…
More Than Pink Walls: What Women-Centric Care Actually Requires
The phrase “patient-centered care” is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the latest episode of the Hear…
Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.
Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at…
Moving Beyond the 10%: A New Era in Preterm Birth Prevention
For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause…